[In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
In this study 411 bacterial isolates from clinical urinary tract infections against some quinolones, azthreonam and trimethoprim + sulfamethoxazole combination were tested. Bactericidal kinetics of norfloxacin , cinoxacin and azthreonam against E. coli ATCC 25922 was determined. Both MICs values and bactericidal activities have shown that fluoroquinolones are more active against all Gram-positive and Gram-negative bacteria tested than the other drugs.
D042462:4-Quinolones; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001398:Aztreonam / Q000494:pharmacology; D002937:Cinoxacin / Q000494:pharmacology; D002939:Ciprofloxacin / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009643:Norfloxacin / Q000494:pharmacology*; D015242:Ofloxacin; D010078:Oxazines / Q000494:pharmacology; D010876:Pipemidic Acid / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D015363:Quinolones; D013420:Sulfamethoxazole / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000382:microbiology*
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D010078:Oxazines; D011804:Quinolines; D015363:Quinolones; C021083:rosoxacin; D002939:Ciprofloxacin; D015242:Ofloxacin; D014295:Trimethoprim; D001398:Aztreonam; D013420:Sulfamethoxazole; D002937:Cinoxacin; D010876:Pipemidic Acid; D009643:Norfloxacin
Attivita' comparativa in vitro di norfloxacina nei confronti di batteri patogeni del tratto urinario.